search
Back to results

Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase

Primary Purpose

Overweight, Obesity

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Chronic consumption of chili pepper extract
Chronic consumption of matching placebo
Sponsored by
Ajinomoto USA, INC.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight focused on measuring Body weight, Body composition, Resting metabolic rate and fat oxidation in men, class I obese

Eligibility Criteria

25 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Is overweight or obese but otherwise generally healthy who interested in losing weight
  • BMI of 25 to 35 kg/m2
  • Waist/hip ratio of 0.9 or more for male and 0.85 for female.

Exclusion Criteria:

  • Type 1 or 2 diabetes mellitus
  • cardiovascular disease (other than mild, controlled hypertension or dislidemia)
  • On a weight-loss program within six months

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    1

    2

    Arm Description

    Oral ingestion of 6mg chili pepper extract

    Oral ingestion of 0 mg chili pepper extract (matching placebo)

    Outcomes

    Primary Outcome Measures

    body weight and body composition

    Secondary Outcome Measures

    resting metabolic rate and substrate oxidation

    Full Information

    First Posted
    January 18, 2009
    Last Updated
    January 20, 2009
    Sponsor
    Ajinomoto USA, INC.
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00825838
    Brief Title
    Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase
    Official Title
    A Randomized Double-Blind Placebo-Controlled Clinical Trial of a Purified Chili Pepper Extract (CH-19 Sweet Extract) to Evaluate Its Safety and Efficacy for Weight and Fat Loss and Metabolism Change in Overweight or Obese Healthy Male and Female Adults
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2009
    Overall Recruitment Status
    Completed
    Study Start Date
    April 2006 (undefined)
    Primary Completion Date
    October 2006 (Actual)
    Study Completion Date
    March 2007 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Ajinomoto USA, INC.

    4. Oversight

    5. Study Description

    Brief Summary
    The purpose of this study is to test the safety and effectiveness of a purified extract of CH-19 Sweet, containing capsinoids.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Overweight, Obesity
    Keywords
    Body weight, Body composition, Resting metabolic rate and fat oxidation in men, class I obese

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantInvestigator
    Allocation
    Randomized
    Enrollment
    80 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    1
    Arm Type
    Experimental
    Arm Description
    Oral ingestion of 6mg chili pepper extract
    Arm Title
    2
    Arm Type
    Placebo Comparator
    Arm Description
    Oral ingestion of 0 mg chili pepper extract (matching placebo)
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Chronic consumption of chili pepper extract
    Intervention Description
    6mg chili pepper extract per day in two divided doses (before the morning meal and before the evening meal) up to 12 weeks.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Chronic consumption of matching placebo
    Intervention Description
    0mg chili pepper extract (matching placebo) per day in two divided doses (before the morning meal and before the evening meal) up to 12 weeks.
    Primary Outcome Measure Information:
    Title
    body weight and body composition
    Time Frame
    12 weeks
    Secondary Outcome Measure Information:
    Title
    resting metabolic rate and substrate oxidation
    Time Frame
    12 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    25 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Is overweight or obese but otherwise generally healthy who interested in losing weight BMI of 25 to 35 kg/m2 Waist/hip ratio of 0.9 or more for male and 0.85 for female. Exclusion Criteria: Type 1 or 2 diabetes mellitus cardiovascular disease (other than mild, controlled hypertension or dislidemia) On a weight-loss program within six months
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Soren Snitker, M.D., Ph.D.
    Organizational Affiliation
    University of Maryland, Baltimore
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Yoshiyuki Fujishima, D. Phil.
    Organizational Affiliation
    Ajinomoto USA, INC.
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase

    We'll reach out to this number within 24 hrs